Cell and gene therapies (CGT) offer immense potential for healthcare – opening up countless possibilities for saving and improving lives, which were previously unavailable through existing
In May, the UK Life Sciences Council, a biannual meeting between ministers and global life sciences industry leaders, met to discuss the sector’s economic potential and h
Industry stakeholders have moved beyond considering patients as clinical trial “subjects”, and instead recognise the tremendous value of viewing those most impacted by a disease as partners
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho
